Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Iovance Biotherapeutics Inc (IOVA)

Iovance Biotherapeutics Inc (IOVA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,914,306
  • Shares Outstanding, K 157,168
  • Annual Sales, $ 0 K
  • Annual Income, $ -342,250 K
  • 60-Month Beta 0.47
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.57
Trade IOVA with:

Options Overview Details

View History
  • Implied Volatility 93.19% ( -2.98%)
  • Historical Volatility 57.34%
  • IV Percentile 48%
  • IV Rank 38.36%
  • IV High 130.39% on 03/23/22
  • IV Low 70.03% on 11/17/21
  • Put/Call Vol Ratio 1.67
  • Today's Volume 905
  • Volume Avg (30-Day) 1,492
  • Put/Call OI Ratio 0.16
  • Today's Open Interest 56,489
  • Open Int (30-Day) 55,628

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -0.61
  • Number of Estimates 6
  • High Estimate -0.54
  • Low Estimate -0.66
  • Prior Year -0.55
  • Growth Rate Est. (year over year) -10.91%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.99 +10.83%
on 08/01/22
13.44 -9.37%
on 07/20/22
+0.61 (+5.27%)
since 07/05/22
3-Month
6.18 +97.09%
on 06/02/22
15.65 -22.17%
on 05/23/22
-2.65 (-17.87%)
since 05/05/22
52-Week
6.18 +97.09%
on 06/02/22
27.96 -56.44%
on 10/14/21
-11.75 (-49.10%)
since 08/05/21

Most Recent Stories

More News
Iovance (IOVA) Q2 Earnings Miss, Lifileucel BLA on Track

Iovance Biotherapeutics (IOVA) reports a wider-than-expected second-quarter loss. The company is on track to initiate a rolling BLA submission for lifileucel in melanoma later this month.

BMY : 72.12 (unch)
MRK : 87.41 (+0.68%)
CLLS : 3.46 (+10.90%)
IOVA : 12.18 (-2.87%)
Iovance Biotherapeutics Reports Second Quarter and First Half 2022 Financial Results and Corporate Updates

First Biologics License Application (BLA) Submission on Track in August 2022 SAN CARLOS, Calif., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Iovance...

IOVA : 12.18 (-2.87%)
Iovance Biotherapeutics to Host Second Quarter Financial Results Conference Call and Webcast on Thursday, August 4, 2022

SAN CARLOS, Calif., July 27, 2022 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T...

IOVA : 12.18 (-2.87%)
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

SAN CARLOS, Calif., July 22, 2022 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T...

IOVA : 12.18 (-2.87%)
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?

Smart Beta ETF report for XBI

XBI : 92.30 (+4.05%)
IBB : 131.44 (+0.97%)
FATE : 33.42 (+2.67%)
FBT : 149.25 (+0.65%)
IOVA : 12.18 (-2.87%)
TWST : 52.77 (+12.68%)
Iovance (IOVA) Pipeline Aids Growth Amid Lack of Marketed Drugs

Iovance (IOVA) is progressing well with the clinical development of its pipeline candidates. It expects to file a BLA with the FDA, seeking approval for its lead candidate to treat metastatic melanoma,...

BMY : 72.12 (unch)
MRK : 87.41 (+0.68%)
CLLS : 3.46 (+10.90%)
IOVA : 12.18 (-2.87%)
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

SAN CARLOS, Calif., June 17, 2022 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T...

IOVA : 12.18 (-2.87%)
Iovance Biotherapeutics Appoints Wendy L. Dixon, Ph.D., to Board of Directors

SAN CARLOS, Calif., June 13, 2022 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T...

IOVA : 12.18 (-2.87%)
Iovance Biotherapeutics to Present at Upcoming Conferences

SAN CARLOS, Calif., June 08, 2022 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T...

IOVA : 12.18 (-2.87%)
Why Iovance Stock Leaped 17% Higher Today

Several insiders have been purchasing the company's common shares lately.

IOVA : 12.18 (-2.87%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Iovance Biotherapeutics is a clinical-stage pharmaceutical company primarily focused on the development and commercialization of novel T cell-based cancer immunotherapies. These immunotherapies use Generation 2 ('Gen 2') tumor infiltrating lymphocyte (TIL), which harnesses the power of a patient's own...

See More

Key Turning Points

3rd Resistance Point 13.72
2nd Resistance Point 13.02
1st Resistance Point 12.60
Last Price 12.18
1st Support Level 11.48
2nd Support Level 10.78
3rd Support Level 10.36

See More

52-Week High 27.96
Fibonacci 61.8% 19.64
Fibonacci 50% 17.07
Fibonacci 38.2% 14.50
Last Price 12.18
52-Week Low 6.18

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar